Approval · Notice of Compliance 628 · 2002
ZADITEN: Notice of Compliance 628
Issued November 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 628
- Date
- November 4, 2002
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Pediatric asthma prophylactic, antiallergic agent
Products in this notice
Medicinal ingredients
- KETOTIFEN FUMARATE 1 MG per TAB
- KETOTIFEN FUMARATE 1 MG per 5ML